logo

For the Inventor, By the Inventor

Sayama, Japan

Takeo Deushi

USPTO Granted Patents = 15


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Higashimurayama, JP (1980 - 1985)
  • Sayama, JP (1992 - 2002)

Company Filing History:

goldMedal15 out of 591 
 
Kowa Company Limited
 patents

Years Active: 1980-2002

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 6337334 - Pyrimidine derivatives (2002-01-08),
2. 6121286 - Tetrazole derivatives (2000-09-19),
3. 6117886 - Tetrazole derivatives (2000-09-12),
4. 6008224 - Pyrimidine derivatives (1999-12-28),
5. 5883092 - Pyrimidine derivatives as endothelin antagonists (1999-03-16),
6. 5541169 - Azoxy compound (1996-07-30),
7. 5264559 - Azoxy compounds (1993-11-23),
8. 5093480 - Azoxy compounds (1992-03-03),
9. 4515942 - Antibiotics KA-6606 XII, XIII, XV, XVI and XVII (1985-05-07),
10. 4425430 - Process for production of antibiotics and novel antibiotics produced (1984-01-10),
11. 4389486 - Biologically pure culture (1983-06-21),
12. 4329426 - Process for preparation of antibiotics and biologically pure culture for (1982-05-11),
13. 4328307 - Novel antibiotics, process for preparation thereof and biologically pure (1982-05-04),
14. 4312858 - Antibiotic KA-7038 and compositions containing same (1982-01-26),
15. 4206206 - Antibiotics of the KA-6606 series and pharmaceutical compositions thereof (1980-06-03),

Title: **The Innovative Mind of Takeo Deushi**

Introduction

Takeo Deushi, a prominent inventor based in Sayama, Japan, has made significant contributions to the field of medicinal chemistry through his innovative research and development. With an impressive portfolio of 15 patents, Deushi has established himself as a leading figure within the pharmaceutical industry, particularly known for his work with pyrimidine and tetrazole derivatives.

Latest Patents

Among Deushi's latest innovations is a tetrazole derivative, which is represented by a specific formula. This compound, characterized by various substituents including hydrogen atoms, hydroxyl groups, and lower alkyl groups, exhibits remarkable therapeutic potential. The invention is notable for its excellent antileukotriene and antihistaminic activities, making it a valuable asset in the prevention and treatment of conditions such as asthma. This advancement in medicine highlights Deushi's commitment to addressing critical health issues through innovative pharmaceutical solutions.

Career Highlights

Takeo Deushi’s career is marked by his tenure at Kowa Company Limited, a respected entity in the pharmaceutical realm. His dedication to research and his ability to translate scientific ideas into viable products have greatly contributed to the company's success and reputation. Deushi's work exemplifies the intersection of creativity and scientific rigor, illustrating his role as a vital contributor to medical advancements.

Collaborations

Throughout his career, Deushi has collaborated with esteemed colleagues, including Toshihito Mori and Akio Iwasaki. These partnerships have fostered a dynamic working environment that encourages the sharing of ideas and interdisciplinary approaches to tackling complex scientific challenges. Together, they have pushed the boundaries of medicinal research, yielding patents that continue to influence the industry.

Conclusion

Takeo Deushi stands out as an innovative thinker whose work has led to significant advancements in the field of pharmaceuticals. His latest patents reflect not just his expertise in chemistry but also his dedication to improving healthcare. Through his ongoing contributions, Deushi not only enhances the reputation of Kowa Company Limited but also positively impacts patients' lives around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…